Bespoke Extracts (BSPK) EPS (Weighted Average and Diluted) (2018 - 2025)
Bespoke Extracts' (BSPK) quarterly EPS (Weighted Average and Diluted) came in at -$0.01 in Q3 2025, up 66.67% year-on-year from -$0.01 in Q3 2024, and up 50.0% quarter-over-quarter from -$0.02 in Q2 2025.
Bespoke Extracts (BSPK) EPS (Weighted Average and Diluted) (2018 - 2025) Analysis & Trends
Bespoke Extracts has disclosed EPS (Weighted Average and Diluted) across 7 years of filings, most recently posting -$0.01 for Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$0.01, up 66.67% year-over-year; the trailing twelve-month figure through Sep 2025 was -$0.07 (up 41.67% YoY), and the FY2024 annual result was -$0.1, up 33.33% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.01 for Q3 2025 at Bespoke Extracts, up from -$0.02 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.7 in Q3 2021 to a low of -$0.14 in Q1 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.03 (2023), against an average of -$0.0.
- Across the five-year window, EPS (Weighted Average and Diluted) soared 78.57% in 2023 and changed 0.0% in 2024, its largest moves.
- Bespoke Extracts' EPS (Weighted Average and Diluted) stood at $0.7 in 2021, then plunged by 105.75% to -$0.04 in 2022, then climbed by 25.0% to -$0.03 in 2023, then jumped by 33.33% to -$0.02 in 2024, then jumped by 50.0% to -$0.01 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.01 (Q3 2025), -$0.02 (Q2 2025), and -$0.02 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Bespoke Extracts | - | - | 234,175.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.13 |
| Mar 31, 2022 | -0.14 |
| Aug 31, 2021 | 0.70 |
| Aug 31, 2019 | -0.01 |
| May 31, 2019 | -0.01 |
| Aug 31, 2018 | -0.05 |
| May 31, 2018 | -0.07 |